INSERM U1231, Labex LIPSTIC and Label of Excellence from la Ligue Nationale Contre le Cancer, 21000, Dijon, France.
Faculty of Medicine and Pharmacy, University of Burgundy, 21000, Dijon, France.
Sci Rep. 2024 Feb 20;14(1):4234. doi: 10.1038/s41598-024-54507-w.
During labor, monocytes infiltrate massively the myometrium and differentiate into macrophages secreting high levels of reactive oxygen species and of pro-inflammatory cytokines (i.e. IL-1β), leading to myometrial contraction. Although IL-1β is clearly implicated in labor, its function and that of the inflammasome complex that cleaves the cytokine in its active form, has never been studied on steps preceding contraction. In this work, we used our model of lipopolysaccharide-induced preterm labor to highlight their role. We demonstrated that IL-1β was secreted by the human myometrium during labor or in presence of infection and was essential for myometrial efficient contractions as its blockage with an IL-1 receptor antagonist (Anakinra) or a neutralizing antibody completely inhibited the induced contractions. We evaluated the implication of the inflammasome on myometrial contractions and differentiation stages of labor onset. We showed that the effects of macrophage-released IL-1β in myometrial cell transactivation were blocked by inhibition of the inflammasome, suggesting that the inflammasome by producing IL-1β was essential in macrophage/myocyte crosstalk during labor. These findings provide novel innovative approaches in the management of preterm labor, specifically the use of an inflammasome inhibitor to block the precursor stages of labor before the acquisition of the contractile phenotype.
在分娩过程中,单核细胞大量浸润子宫肌层并分化为巨噬细胞,分泌大量活性氧和促炎细胞因子(如 IL-1β),导致子宫收缩。尽管 IL-1β 显然与分娩有关,但它的功能以及切割细胞因子为其活性形式的炎症小体复合物的功能,从未在收缩前的步骤中进行过研究。在这项工作中,我们使用了我们的脂多糖诱导早产模型来强调它们的作用。我们证明了在分娩或感染期间,IL-1β 由人子宫肌层分泌,并且对于有效的子宫收缩是必需的,因为用 IL-1 受体拮抗剂(Anakinra)或中和抗体阻断其分泌完全抑制了诱导的收缩。我们评估了炎症小体对子宫收缩和分娩开始阶段的分化的影响。我们表明,巨噬细胞释放的 IL-1β 对子宫肌细胞转激活的作用被炎症小体的抑制所阻断,这表明炎症小体通过产生 IL-1β 在分娩期间的巨噬细胞/肌细胞相互作用中是必不可少的。这些发现为早产的管理提供了新的创新方法,特别是使用炎症小体抑制剂在获得收缩表型之前阻断分娩的前体阶段。